MDS

>

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Latest News

Illustration of blood cell.
Bexmarilimab Plus Vidaza Elicit Responses in Myelodysplastic Syndromes

April 16th 2025

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory higher-risk myelodysplastic syndrome.

Illustration of woman.
Sometimes Cancer is a (Welcome) Distraction

April 8th 2025

The EC has approved Rytelo in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome: © Crystal_Light - stock.adobe.com.
EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

March 25th 2025

Illustration of woman with blonde hair.
Looking For The Light After MDS

March 6th 2025

Illustration of woman with blonde hair.
Cancer is Hard Enough Without Infections

February 21st 2025

Video Series
Video Interviews

More News